RxDoctor Payments Data

Chandra Sanwal, DO

Hematology · South Miami, FLNPI 1235662735

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,741 of the $3,294 with a category attached, or 83.2%. It is spread thinly across 32 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $958 and has fallen 65.0% since, to $335 in 2025.

$3,294in general payments, 2019–2025

Across 115 payments — averaging $28.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$363
  • Bristol Myers Squibb$362
  • Seagen Inc.$351
  • Eisai Inc.$335
  • Merck$232
  • Lilly USA, LLC$161
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,74183%
  • Education$55417%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,294 in reported general payments places this provider in the 60th percentile of 79 hematology providers in Florida.

See all hematology providers in Florida

Medicare billing

Part B allowed, 2024
$40,816
Medicare patients
110
Services billed
396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole22$582
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$514
Ondansetron OdtOndansetron15$252
Prochlorperazine Maleate19$205
Dexamethasone11$193
Lidocaine-PrilocaineLidocaine/Prilocaine15$169
Ondansetron Hcl16$124
Levothyroxine Sodium16$74
Folic Acid13$61

Paid to pharmacies, not to this prescriber.

Other hematology in South Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →